Anne Zaki, MD
Ophthalmology · Sun City West, AZNPI 1427014992
Payments from drug & device makers
Across 718 payments — averaging $721.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tarsus Pharmaceuticals, Inc.$238K
- AbbVie$161K
- Dompe US, Inc.$42K
- Sun Pharmaceutical Industries Inc.$27K
- Bausch & Lomb Americas Inc.$19K
- Novartis$12K
- plus $18K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 179 | $238,275 |
| AbbVie(2 entities) | 237 | $161,042 |
| Dompe US, Inc. | 58 | $42,326 |
| Sun Pharmaceutical Industries Inc. | 67 | $27,394 |
| Bausch & Lomb Americas Inc. | 41 | $18,958 |
| Novartis | 19 | $11,907 |
| Shire North American Group Inc | 13 | $7,035 |
| Rxsight Inc | 6 | $2,967 |
| Kala Pharmaceuticals, Inc. | 13 | $2,850 |
| Alcon | 23 | $2,089 |
| Lumenis BE Inc | 1 | $849 |
| Oyster Point Pharma, Inc. | 12 | $593 |
| Glaukos Corporation | 4 | $357 |
| Aerie Pharmaceuticals, Inc. | 12 | $322 |
| Biotissue Holdings Inc. | 4 | $185 |
| Alimera Sciences, Inc. | 1 | $133 |
| Carl Zeiss Meditec USA, Inc. | 2 | $131 |
| Harrow Eye, LLC | 4 | $92 |
| Sight Sciences, Inc. | 4 | $90 |
| Johnson & Johnson Surgical Vision, Inc. | 3 | $84 |
| Genentech USA, Inc. | 1 | $81 |
| Mallinckrodt Hospital Products Inc. | 3 | $72 |
| Heidelberg Engineering, Inc. | 1 | $68 |
| Amgen | 2 | $53 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 2 | $44 |
| Thea Pharma Inc. | 2 | $37 |
| Ivantis, Inc | 1 | $34 |
| Astellas Pharma US Inc | 1 | $22 |
| ANI Pharmaceuticals, Inc. | 1 | $20 |
| Ocular Therapeutix, Inc. | 1 | $17 |
How this compares
$518,128 in reported general payments places this provider in the 95th percentile of 310 ophthalmology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Sun City West
- Wen-Shin LeeSun City West$35K
- Mark BarakatScottsdale$2.9M
- Michael DepenbuschChandler$2.3M
- Ramin SchadluPhoenix$1.8M
- Gerald WalmanSun City$1.7M
- John CasonPhoenix$1.7M
- George ReissGlendale$1.3M
- Warren HillMesa$1.2M
- Benjamin HellerPhoenix$1.1M
- Neal PalejwalaPhoenix$627K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.